DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression

Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MCGIVERN JOSEPH G, WALKER KENNETH W, KHARE TARUNA ARORA, ADLER BEVERLY S, MIRANDA LESLIE P, HU SHAW-FEN SYLVIA, MARTIN FRANCIS H, NGUYEN HUNG Q, GEGG, JR. COLIN V, SULLIVAN JOHN K
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MCGIVERN JOSEPH G
WALKER KENNETH W
KHARE TARUNA ARORA
ADLER BEVERLY S
MIRANDA LESLIE P
HU SHAW-FEN SYLVIA
MARTIN FRANCIS H
NGUYEN HUNG Q
GEGG, JR. COLIN V
SULLIVAN JOHN K
description Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2009299044A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2009299044A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2009299044A13</originalsourceid><addsrcrecordid>eNqNjLsKwkAQRdNYiPoPA9ZCjDYpgw-sbNQ6rJsbHdidWXZXyeer6AdY3XPgcMeFbI8NQax2LDeyd_aIbCnrwEIBIXMH6h-J9a1RM1gSGenoCZs1ftkb741jI2ThXKJeI0VY9VcWI5kwhIj0-ZgWo964hNlvJ8V8vztvDgsEbZGCsRDk9nKqyrKu6rpcr5vl6r_qBdiIQ-8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression</title><source>esp@cenet</source><creator>MCGIVERN JOSEPH G ; WALKER KENNETH W ; KHARE TARUNA ARORA ; ADLER BEVERLY S ; MIRANDA LESLIE P ; HU SHAW-FEN SYLVIA ; MARTIN FRANCIS H ; NGUYEN HUNG Q ; GEGG, JR. COLIN V ; SULLIVAN JOHN K</creator><creatorcontrib>MCGIVERN JOSEPH G ; WALKER KENNETH W ; KHARE TARUNA ARORA ; ADLER BEVERLY S ; MIRANDA LESLIE P ; HU SHAW-FEN SYLVIA ; MARTIN FRANCIS H ; NGUYEN HUNG Q ; GEGG, JR. COLIN V ; SULLIVAN JOHN K</creatorcontrib><description>Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.</description><language>eng</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; SUGARS</subject><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20091203&amp;DB=EPODOC&amp;CC=US&amp;NR=2009299044A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20091203&amp;DB=EPODOC&amp;CC=US&amp;NR=2009299044A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MCGIVERN JOSEPH G</creatorcontrib><creatorcontrib>WALKER KENNETH W</creatorcontrib><creatorcontrib>KHARE TARUNA ARORA</creatorcontrib><creatorcontrib>ADLER BEVERLY S</creatorcontrib><creatorcontrib>MIRANDA LESLIE P</creatorcontrib><creatorcontrib>HU SHAW-FEN SYLVIA</creatorcontrib><creatorcontrib>MARTIN FRANCIS H</creatorcontrib><creatorcontrib>NGUYEN HUNG Q</creatorcontrib><creatorcontrib>GEGG, JR. COLIN V</creatorcontrib><creatorcontrib>SULLIVAN JOHN K</creatorcontrib><title>DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression</title><description>Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLsKwkAQRdNYiPoPA9ZCjDYpgw-sbNQ6rJsbHdidWXZXyeer6AdY3XPgcMeFbI8NQax2LDeyd_aIbCnrwEIBIXMH6h-J9a1RM1gSGenoCZs1ftkb741jI2ThXKJeI0VY9VcWI5kwhIj0-ZgWo964hNlvJ8V8vztvDgsEbZGCsRDk9nKqyrKu6rpcr5vl6r_qBdiIQ-8</recordid><startdate>20091203</startdate><enddate>20091203</enddate><creator>MCGIVERN JOSEPH G</creator><creator>WALKER KENNETH W</creator><creator>KHARE TARUNA ARORA</creator><creator>ADLER BEVERLY S</creator><creator>MIRANDA LESLIE P</creator><creator>HU SHAW-FEN SYLVIA</creator><creator>MARTIN FRANCIS H</creator><creator>NGUYEN HUNG Q</creator><creator>GEGG, JR. COLIN V</creator><creator>SULLIVAN JOHN K</creator><scope>EVB</scope></search><sort><creationdate>20091203</creationdate><title>DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression</title><author>MCGIVERN JOSEPH G ; WALKER KENNETH W ; KHARE TARUNA ARORA ; ADLER BEVERLY S ; MIRANDA LESLIE P ; HU SHAW-FEN SYLVIA ; MARTIN FRANCIS H ; NGUYEN HUNG Q ; GEGG, JR. COLIN V ; SULLIVAN JOHN K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2009299044A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>MCGIVERN JOSEPH G</creatorcontrib><creatorcontrib>WALKER KENNETH W</creatorcontrib><creatorcontrib>KHARE TARUNA ARORA</creatorcontrib><creatorcontrib>ADLER BEVERLY S</creatorcontrib><creatorcontrib>MIRANDA LESLIE P</creatorcontrib><creatorcontrib>HU SHAW-FEN SYLVIA</creatorcontrib><creatorcontrib>MARTIN FRANCIS H</creatorcontrib><creatorcontrib>NGUYEN HUNG Q</creatorcontrib><creatorcontrib>GEGG, JR. COLIN V</creatorcontrib><creatorcontrib>SULLIVAN JOHN K</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MCGIVERN JOSEPH G</au><au>WALKER KENNETH W</au><au>KHARE TARUNA ARORA</au><au>ADLER BEVERLY S</au><au>MIRANDA LESLIE P</au><au>HU SHAW-FEN SYLVIA</au><au>MARTIN FRANCIS H</au><au>NGUYEN HUNG Q</au><au>GEGG, JR. COLIN V</au><au>SULLIVAN JOHN K</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression</title><date>2009-12-03</date><risdate>2009</risdate><abstract>Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2009299044A1
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
SUGARS
title DNA encoding chimeric toxin peptide fusion proteins and vectors and mammalian cells for recombinant expression
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A40%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MCGIVERN%20JOSEPH%20G&rft.date=2009-12-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2009299044A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true